Memantine for the prevention or reduction of suicidality and...

Details Memantine for the prevention or reduction of suicidality and... Memantine for the prevention or reduction of suicidality and...

A - Human Necessities

61

K

A61K 31/13 (2006.01) A61P 25/24 (2006.01)

Patent

CA 2546496

The present invention relates to the treatment of major depressive disorder (MDD), and the prevention of suicidality associated therewith, using the uncompetitive NMDA receptor antagonist memantine.

La présente invention concerne le traitement d'un trouble dépressif majeur (TDM) et la prévention d'une tendance suicidaire associée à ce trouble au moyen d'une mémantine sous forme d'antagoniste du récepteur NMDA incompétitif.

Affiliated with

Also associated with

Rating

Memantine for the prevention or reduction of suicidality and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Memantine for the prevention or reduction of suicidality and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Memantine for the prevention or reduction of suicidality and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1869427